- Home
- STG vs IKNA Comparison
STG vs IKNA Comparison
Compare STG & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- IKNA
- Stock Information
- Founded
- STG 2003
- IKNA 2016
- Country
- STG China
- IKNA United States
- Employees
- STG N/A
- IKNA N/A
- Industry
- STG Other Consumer Services
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- IKNA Health Care
- Exchange
- STG Nasdaq
- IKNA Nasdaq
- Market Cap
- STG 73.4M
- IKNA 63.7M
- IPO Year
- STG 2018
- IKNA 2021
- Fundamental
- Price
- STG $8.92
- IKNA $1.36
- Analyst Decision
- STG
- IKNA Strong Buy
- Analyst Count
- STG 0
- IKNA 1
- Target Price
- STG N/A
- IKNA $4.00
- AVG Volume (30 Days)
- STG 17.3K
- IKNA 60.0K
- Earning Date
- STG 08-15-2025
- IKNA 08-07-2025
- Dividend Yield
- STG N/A
- IKNA N/A
- EPS Growth
- STG N/A
- IKNA N/A
- EPS
- STG 3.09
- IKNA N/A
- Revenue
- STG $269,356,990.00
- IKNA N/A
- Revenue This Year
- STG N/A
- IKNA N/A
- Revenue Next Year
- STG N/A
- IKNA N/A
- P/E Ratio
- STG $2.42
- IKNA N/A
- Revenue Growth
- STG N/A
- IKNA N/A
- 52 Week Low
- STG $4.25
- IKNA $0.97
- 52 Week High
- STG $11.06
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- STG 80.31
- IKNA 53.81
- Support Level
- STG $5.51
- IKNA $1.31
- Resistance Level
- STG $5.88
- IKNA $1.42
- Average True Range (ATR)
- STG 0.56
- IKNA 0.05
- MACD
- STG 0.28
- IKNA -0.00
- Stochastic Oscillator
- STG 92.75
- IKNA 45.45
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.